Sensient Technologies Corporation
Reports Results for the Quarter Ended September 30, 2024
MILWAUKEE — October 25, 2024 — Sensient Technologies Corporation (NYSE: SXT), a leading provider of flavors and
colors for the food, pharmaceutical, and personal care markets, today reported financial results for the third quarter ended September 30, 2024.
Third Quarter Consolidated Results
|
• |
Reported revenue increased 7.9% to $392.6 million in the third quarter of 2024 versus last year’s third quarter results of $363.8 million. On a local currency basis(1), revenue increased
8.6%.
|
|
• |
Reported operating income increased 13.4% to $50.5 million compared to $44.5 million recorded in the third quarter of 2023. In the third quarter of 2024, the Company recorded $1.2 million of costs
related to its Portfolio Optimization Plan. Local currency adjusted operating income(1) and local currency adjusted EBITDA(1) increased 17.1% and 12.8%, respectively, in the third quarter.
|
|
• |
Reported diluted earnings per share increased 2.7% to 77 cents in the third quarter of 2024 compared to 75 cents in the third quarter of 2023. Local currency adjusted diluted EPS(1)
increased 8.0% to 80 cents in the third quarter.
|
“I am pleased with our results this quarter and remain confident that our solid
performance and volume growth will allow the Company to achieve our 2024 guidance,” said Paul Manning, Sensient’s Chairman, President, and Chief Executive Officer.
Third Quarter Group Results
| |
|
Reported
|
|
Local Currency(1)
|
|
Revenue
|
|
Quarter
|
|
Year-to-Date
|
|
Quarter
|
|
Year-to-Date
|
|
Flavors & Extracts
|
|
6.4%
|
|
8.5%
|
|
6.8%
|
|
8.3%
|
|
Color
|
|
11.8%
|
|
5.0%
|
|
13.0%
|
|
5.2%
|
|
Asia Pacific
|
|
13.6%
|
|
6.9%
|
|
13.4%
|
|
9.4%
|
|
Total Revenue
|
|
7.9%
|
|
6.7%
|
|
8.6%
|
|
6.9%
|
| |
|
Reported
|
|
Adjusted Local Currency(1)
|
|
Operating Income
|
|
Quarter
|
|
Year-to-Date
|
|
Quarter
|
|
Year-to-Date
|
|
Flavors & Extracts
|
|
12.1%
|
|
8.7%
|
|
12.8%
|
|
8.8%
|
|
Color
|
|
30.0%
|
|
10.7%
|
|
30.9%
|
|
10.8%
|
|
Asia Pacific
|
|
15.0%
|
|
4.2%
|
|
15.3%
|
|
7.5%
|
|
Total Operating Income
|
|
13.4%
|
|
1.8%
|
|
17.1%
|
|
6.4%
|
| |
|
|
|
|
|
|
|
|
The Flavors & Extracts Group reported third quarter 2024 revenue of $203.3 million, an increase of $12.3 million versus the prior year’s third
quarter. Segment operating income was $25.9 million in the third quarter of 2024, an increase of $2.8 million compared to the prior year’s third quarter. The Group’s higher revenue and operating income were driven by higher volumes and pricing.
The Color Group reported revenue of $162.1 million in the third quarter of 2024, an increase of $17.1 million compared to the prior year’s third
quarter. Segment operating income was $29.8 million in the third quarter of 2024, an increase of $6.9 million compared to the prior year’s third quarter results. The Group’s increased revenue and operating income were primarily a result of the
higher volumes across all product lines and higher pricing.
The Asia Pacific Group reported revenue of $41.8 million in the third quarter of 2024, an increase of $5.0 million compared to the prior year’s third
quarter. The Group benefited from higher revenues across nearly all geographies. Segment operating income was $9.3 million in the quarter, an increase of $1.2 million compared to the prior year’s third quarter. The higher operating income is
primarily a result of higher volumes.
Corporate & Other reported operating expenses of $14.5 million in the third quarter of 2024, compared to $9.6 million of operating expenses
reported in the prior year’s third quarter. In the third quarter of 2024, the Company recorded $1.2 million of Portfolio Optimization Plan costs in Corporate & Other. Local currency adjusted operating expenses(1) for Corporate &
Other increased $3.7 million compared to the prior year’s third quarter, primarily due to the higher performance-based compensation costs recorded in the third quarter of 2024 compared to the low comparable amount recorded in the third quarter of
2023.
2024 Outlook
| |
|
|
|
|
|
Metric
|
|
Updated Guidance
|
|
Prior Guidance
|
| |
|
|
|
|
|
Local Currency Revenue(1)
|
|
High Single-Digit Growth
|
|
Mid-to High Single-Digit Growth
|
| |
|
|
|
|
|
Local Currency Adjusted EBITDA(1)
|
|
High Single-Digit Growth
|
|
Mid-to High Single-Digit Growth
|
| |
|
|
|
|
|
Diluted EPS (GAAP)
|
|
Between $2.77 and $2.87*
|
|
Between $2.77 and $2.87*
|
| |
|
|
|
|
|
Local Currency Adjusted Diluted EPS(1)
|
|
Mid-Single-Digit Growth
|
|
Mid-Single-Digit Growth
|
| |
|
|
|
|
|
*Includes approximately 18 cents of Portfolio Optimization Plan costs.
|
|
|
This guidance is based on current conditions and economic and market trends in the markets in which the Company operates and is subject to various
risks and uncertainties as described below.
|
(1) |
Please refer to “Reconciliation of Non-GAAP Amounts” at the end of this release for more information regarding our non-GAAP
financial measures.
|
USE OF NON-GAAP FINANCIAL MEASURES
The Company’s non-GAAP financial measures eliminate the impact of certain items, which, depending on the measure, include: currency movements,
depreciation and amortization, Portfolio Optimization Plan costs, and non-cash share-based compensation. These measures are provided to enhance the overall understanding of the Company’s performance when viewed together with the GAAP results. Refer
to “Reconciliation of Non-GAAP Amounts” at the end of this release.
CONFERENCE CALL
The Company will host a conference call to discuss its 2024 third quarter financial results at 8:30 a.m. CDT today, Friday, October 25, 2024.
Investors may access the live webcast, including presentation slides, on the Company’s web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078.
A webcast replay will be available on the Company’s web site following the call. The call transcript will be available on the Company’s web site on
or after October 29, 2024.
This release contains statements that may constitute “forward-looking statements” within the meaning of Federal securities laws
including under “2024 Outlook” above. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, and other factors concerning the Company’s operations and business environment.
Important factors that could cause actual results to differ materially from those suggested by these forward-looking statements and that could adversely affect the Company’s future financial performance include the following: the Company’s ability
to manage general business, economic, and capital market conditions, including actions taken by customers in response to such market conditions, and the impact of recessions and economic downturns; the impact of macroeconomic and geopolitical
volatility, including inflation and shortages impacting the availability and cost of raw materials, energy, and other supplies, disruptions and delays in the Company’s supply chain, and the conflicts between Russia and Ukraine and Israel and Hamas
and other parties in the Middle East; the availability and cost of labor, logistics, and transportation; the pace and nature of new product introductions by the Company and the Company’s customers; the Company’s ability to anticipate and respond to
changing consumer preferences and changing technologies; the Company’s ability to successfully implement its growth strategies; the outcome of the Company’s various productivity-improvement and cost-reduction efforts, acquisition and divestiture
activities, and Portfolio Optimization Plan; industry, regulatory, legal, and economic factors related to the Company’s domestic and international business; the effects of tariffs, trade barriers, and disputes; growth in markets for products in
which the Company competes; industry and customer acceptance of price increases; actions by competitors; the Company’s ability to enhance its innovation efforts and drive cost efficiencies; currency exchange rate fluctuations; and other factors
included in “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and in other documents that the Company files with the SEC. The risks and uncertainties identified above are not the only risks the Company
faces. Additional risks and uncertainties not presently known to the Company or that it currently believes to be immaterial also may adversely affect the Company. Should any known or unknown risks and uncertainties develop into actual events, these
developments could have material adverse effects on our business, financial condition, and results of operations. This release contains time-sensitive information that reflects management’s best analysis only as of the date of this release. Except
to the extent required by applicable laws, the Company does not undertake to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied herein will not
be realized.
ABOUT SENSIENT TECHNOLOGIES
Sensient Technologies Corporation is a leading global manufacturer and marketer of colors, flavors, and other specialty ingredients. Sensient uses
advanced technologies and robust global supply chain capabilities to develop specialized solutions for food and beverages, as well as products that serve the pharmaceutical, nutraceutical, and personal care industries. Sensient’s customers range in
size from small entrepreneurial businesses to major international manufacturers representing some of the world’s best-known brands. Sensient is headquartered in Milwaukee, Wisconsin.
www.sensient.com
|
Consolidated Statements of Earnings
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
2024
|
|
|
2023
|
|
|
% Change
|
|
|
2024
|
|
|
2023
|
|
|
% Change
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
$
|
392,613
|
|
|
$
|
363,829
|
|
|
|
7.9
|
%
|
|
$
|
1,180,808
|
|
|
$
|
1,107,148
|
|
|
|
6.7
|
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold
|
|
|
262,209
|
|
|
|
250,202
|
|
|
|
4.8
|
%
|
|
|
793,133
|
|
|
|
746,681
|
|
|
|
6.2
|
%
|
|
Selling and administrative expenses
|
|
|
79,884
|
|
|
|
69,096
|
|
|
|
15.6
|
%
|
|
|
238,092
|
|
|
|
213,507
|
|
|
|
11.5
|
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating income
|
|
|
50,520
|
|
|
|
44,531
|
|
|
|
13.4
|
%
|
|
|
149,583
|
|
|
|
146,960
|
|
|
|
1.8
|
%
|
|
Interest expense
|
|
|
7,696
|
|
|
|
6,294
|
|
|
|
|
|
|
|
22,394
|
|
|
|
18,648
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings before income taxes
|
|
|
42,824
|
|
|
|
38,237
|
|
|
|
|
|
|
|
127,189
|
|
|
|
128,312
|
|
|
|
|
|
|
Income taxes
|
|
|
10,134
|
|
|
|
6,694
|
|
|
|
|
|
|
|
32,627
|
|
|
|
29,085
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
32,690
|
|
|
$
|
31,543
|
|
|
|
3.6
|
%
|
|
$
|
94,562
|
|
|
$
|
99,227
|
|
|
|
(4.7
|
%)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per share of common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.78
|
|
|
$
|
0.75
|
|
|
|
|
|
|
$
|
2.24
|
|
|
$
|
2.36
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
0.77
|
|
|
$
|
0.75
|
|
|
|
|
|
|
$
|
2.23
|
|
|
$
|
2.35
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
42,159
|
|
|
|
42,045
|
|
|
|
|
|
|
|
42,139
|
|
|
|
42,020
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
42,429
|
|
|
|
42,233
|
|
|
|
|
|
|
|
42,377
|
|
|
|
42,241
|
|
|
|
|
|
|
Results by Segment
|
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
2024
|
|
|
2023
|
|
|
% Change
|
|
|
2024
|
|
|
2023
|
|
|
% Change
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flavors & Extracts
|
|
$
|
203,279
|
|
|
$
|
190,997
|
|
|
|
6.4
|
%
|
|
$
|
605,584
|
|
|
$
|
558,133
|
|
|
|
8.5
|
%
|
|
Color
|
|
|
162,080
|
|
|
|
144,939
|
|
|
|
11.8
|
%
|
|
|
489,805
|
|
|
|
466,563
|
|
|
|
5.0
|
%
|
|
Asia Pacific
|
|
|
41,778
|
|
|
|
36,774
|
|
|
|
13.6
|
%
|
|
|
120,664
|
|
|
|
112,888
|
|
|
|
6.9
|
%
|
|
Intersegment elimination
|
|
|
(14,524
|
)
|
|
|
(8,881
|
)
|
|
|
|
|
|
|
(35,245
|
)
|
|
|
(30,436
|
)
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
|
|
$
|
392,613
|
|
|
$
|
363,829
|
|
|
|
7.9
|
%
|
|
$
|
1,180,808
|
|
|
$
|
1,107,148
|
|
|
|
6.7
|
%
|
|
Operating Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flavors & Extracts
|
|
$
|
25,862
|
|
|
$
|
23,078
|
|
|
|
12.1
|
%
|
|
$
|
75,749
|
|
|
$
|
69,714
|
|
|
|
8.7
|
%
|
|
Color
|
|
|
29,806
|
|
|
|
22,925
|
|
|
|
30.0
|
%
|
|
|
92,987
|
|
|
|
84,027
|
|
|
|
10.7
|
%
|
|
Asia Pacific
|
|
|
9,307
|
|
|
|
8,095
|
|
|
|
15.0
|
%
|
|
|
25,963
|
|
|
|
24,911
|
|
|
|
4.2
|
%
|
|
Corporate & Other
|
|
|
(14,455
|
)
|
|
|
(9,567
|
)
|
|
|
|
|
|
|
(45,116
|
)
|
|
|
(31,692
|
)
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
|
|
$
|
50,520
|
|
|
$
|
44,531
|
|
|
|
13.4
|
%
|
|
$
|
149,583
|
|
|
$
|
146,960
|
|
|
|
1.8
|
%
|
|
Consolidated Condensed Balance Sheets
|
|
September 30,
|
|
|
December 31,
|
|
| |
|
2024
|
|
|
2023
|
|
| |
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
36,969
|
|
|
$
|
28,934
|
|
|
Trade accounts receivable
|
|
|
302,012
|
|
|
|
272,164
|
|
|
Inventories
|
|
|
580,847
|
|
|
|
598,399
|
|
|
Prepaid expenses and other current assets
|
|
|
38,973
|
|
|
|
37,119
|
|
|
Total Current Assets
|
|
|
958,801
|
|
|
|
936,616
|
|
| |
|
|
|
|
|
|
|
|
|
Goodwill & intangible assets (net)
|
|
|
438,220
|
|
|
|
436,177
|
|
|
Property, plant, and equipment (net)
|
|
|
494,619
|
|
|
|
505,277
|
|
|
Other assets
|
|
|
150,972
|
|
|
|
136,437
|
|
| |
|
|
|
|
|
|
|
|
|
Total Assets
|
|
$
|
2,042,612
|
|
|
$
|
2,014,507
|
|
| |
|
|
|
|
|
|
|
|
|
Trade accounts payable
|
|
$
|
119,238
|
|
|
$
|
131,114
|
|
|
Short-term borrowings
|
|
|
17,811
|
|
|
|
13,460
|
|
|
Other current liabilities
|
|
|
119,406
|
|
|
|
91,732
|
|
|
Total Current Liabilities
|
|
|
256,455
|
|
|
|
236,306
|
|
| |
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
|
625,627
|
|
|
|
645,085
|
|
|
Accrued employee and retiree benefits
|
|
|
26,130
|
|
|
|
27,715
|
|
|
Other liabilities
|
|
|
53,949
|
|
|
|
52,077
|
|
|
Shareholders’ Equity
|
|
|
1,080,451
|
|
|
|
1,053,324
|
|
| |
|
|
|
|
|
|
|
|
|
Total Liabilities and Shareholders’ Equity
|
|
$
|
2,042,612
|
|
|
$
|
2,014,507
|
|
Consolidated Statements of Cash Flows
Nine Months Ended September 30,
| |
|
2024
|
|
|
2023
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
Net earnings
|
|
$
|
94,562
|
|
|
$
|
99,227
|
|
|
Adjustments to arrive at net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
45,185
|
|
|
|
43,360
|
|
|
Share-based compensation expense
|
|
|
6,980
|
|
|
|
7,285
|
|
|
Net gain on assets
|
|
|
(210
|
)
|
|
|
(81
|
)
|
|
Portfolio Optimization Plan costs
|
|
|
1,406
|
|
|
|
-
|
|
|
Deferred income taxes
|
|
|
(11,117
|
)
|
|
|
2,082
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
Trade accounts receivable
|
|
|
(32,138
|
)
|
|
|
18,830
|
|
|
Inventories
|
|
|
14,902
|
|
|
|
(21,455
|
)
|
|
Prepaid expenses and other assets
|
|
|
221
|
|
|
|
842
|
|
|
Trade accounts payable and other accrued expenses
|
|
|
(4,664
|
)
|
|
|
(20,572
|
)
|
|
Accrued salaries, wages, and withholdings
|
|
|
16,769
|
|
|
|
(16,749
|
)
|
|
Income taxes
|
|
|
854
|
|
|
|
(6,536
|
)
|
|
Other liabilities
|
|
|
3,011
|
|
|
|
587
|
|
| |
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities
|
|
|
135,761
|
|
|
|
106,820
|
|
| |
|
|
|
|
|
|
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
Acquisition of property, plant, and equipment
|
|
|
(36,088
|
)
|
|
|
(67,718
|
)
|
|
Proceeds from sale of assets
|
|
|
338
|
|
|
|
130
|
|
|
Other investing activities
|
|
|
(1,444
|
)
|
|
|
2,036
|
|
| |
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(37,194
|
)
|
|
|
(65,552
|
)
|
| |
|
|
|
|
|
|
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
Proceeds from additional borrowings
|
|
|
134,432
|
|
|
|
197,577
|
|
|
Debt payments
|
|
|
(154,219
|
)
|
|
|
(174,083
|
)
|
|
Dividends paid
|
|
|
(52,034
|
)
|
|
|
(51,900
|
)
|
|
Other financing activities
|
|
|
(3,317
|
)
|
|
|
(8,034
|
)
|
| |
|
|
|
|
|
|
|
|
|
Net cash used in financing activities
|
|
|
(75,138
|
)
|
|
|
(36,440
|
)
|
| |
|
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
(15,394
|
)
|
|
|
6,236
|
|
| |
|
|
|
|
|
|
|
|
|
Net increase in cash and cash equivalents
|
|
|
8,035
|
|
|
|
11,064
|
|
|
Cash and cash equivalents at beginning of period
|
|
|
28,934
|
|
|
|
20,921
|
|
|
Cash and cash equivalents at end of period
|
|
$
|
36,969
|
|
|
$
|
31,985
|
|
Supplemental Information
Nine Months Ended September 30,
|
|
2024
|
|
|
2023
|
|
| |
|
|
|
|
|
|
|
Dividends paid per share
|
|
$
|
1.23
|
|
|
$
|
1.23
|
|
Reconciliation of Non-GAAP Amounts
The Company’s results for the three and nine months ended September 30, 2024 and 2023 include adjusted operating income, adjusted
net earnings, and adjusted diluted earnings per share, which, in each case, exclude Portfolio Optimization Plan costs.
| |
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
| |
|
2024
|
|
|
2023
|
|
|
% Change
|
|
|
2024
|
|
|
2023
|
|
|
% Change
|
|
|
Operating income (GAAP)
|
|
$
|
50,520
|
|
|
$
|
44,531
|
|
|
|
13.4
|
%
|
|
$
|
149,583
|
|
|
$
|
146,960
|
|
|
|
1.8
|
%
|
|
Portfolio Optimization Plan costs – Cost of products sold
|
|
|
209
|
|
|
|
-
|
|
|
|
|
|
|
|
523
|
|
|
|
-
|
|
|
|
|
|
Portfolio Optimization Plan costs – Selling and administrative expenses
|
|
|
1,002
|
|
|
|
-
|
|
|
|
|
|
|
|
5,252
|
|
|
|
-
|
|
|
|
|
|
|
Adjusted operating income
|
|
$
|
51,731
|
|
|
$
|
44,531
|
|
|
|
16.2
|
%
|
|
$
|
155,358
|
|
|
$
|
146,960
|
|
|
|
5.7
|
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (GAAP)
|
|
$
|
32,690
|
|
|
$
|
31,543
|
|
|
|
3.6
|
%
|
|
$
|
94,562
|
|
|
$
|
99,227
|
|
|
|
(4.7
|
%)
|
|
Portfolio Optimization Plan costs, before tax
|
|
|
1,211
|
|
|
|
-
|
|
|
|
|
|
|
|
5,775
|
|
|
|
-
|
|
|
|
|
|
|
Tax impact of Portfolio Optimization Plan costs(1)
|
|
|
(17
|
)
|
|
|
-
|
|
|
|
|
|
|
|
(586
|
)
|
|
|
-
|
|
|
|
|
|
|
Adjusted net earnings
|
|
$
|
33,884
|
|
|
$
|
31,543
|
|
|
|
7.4
|
%
|
|
$
|
99,751
|
|
|
$
|
99,227
|
|
|
|
0.5
|
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share (GAAP)
|
|
$
|
0.77
|
|
|
$
|
0.75
|
|
|
|
2.7
|
%
|
|
$
|
2.23
|
|
|
$
|
2.35
|
|
|
|
(5.1
|
%)
|
|
Portfolio Optimization Plan costs, net of tax
|
|
|
0.03
|
|
|
|
-
|
|
|
|
|
|
|
|
0.12
|
|
|
|
-
|
|
|
|
|
|
|
Adjusted diluted earnings per share
|
|
$
|
0.80
|
|
|
$
|
0.75
|
|
|
|
6.7
|
%
|
|
$
|
2.35
|
|
|
$
|
2.35
|
|
|
|
0.0
|
%
|
Note: Earnings per share calculations may not foot due to rounding differences.
(1) Tax impact adjustments were determined based on the nature of the underlying non-GAAP adjustments and their
relevant jurisdictional tax rates.
|
Results by Segment
|
|
Three Months Ended September 30,
|
|
| |
|
|
|
|
|
|
|
Adjusted
|
|
|
|
|
|
|
|
|
Adjusted
|
|
|
Operating Income
|
|
2024
|
|
|
Adjustments(2)
|
|
|
2024
|
|
|
2023
|
|
|
Adjustments(2)
|
|
|
2023
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flavors & Extracts
|
|
$
|
25,862
|
|
|
$
|
-
|
|
|
$
|
25,862
|
|
|
$
|
23,078
|
|
|
$
|
-
|
|
|
$
|
23,078
|
|
|
Color
|
|
|
29,806
|
|
|
|
-
|
|
|
|
29,806
|
|
|
|
22,925
|
|
|
|
-
|
|
|
|
22,925
|
|
|
Asia Pacific
|
|
|
9,307
|
|
|
|
-
|
|
|
|
9,307
|
|
|
|
8,095
|
|
|
|
-
|
|
|
|
8,095
|
|
|
Corporate & Other
|
|
|
(14,455
|
)
|
|
|
1,211
|
|
|
|
(13,244
|
)
|
|
|
(9,567
|
)
|
|
|
-
|
|
|
|
(9,567
|
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
|
|
$
|
50,520
|
|
|
$
|
1,211
|
|
|
$
|
51,731
|
|
|
$
|
44,531
|
|
|
$
|
-
|
|
|
$
|
44,531
|
|
|
Results by Segment
|
|
Nine Months Ended September 30,
|
|
| |
|
|
|
|
|
|
|
Adjusted
|
|
|
|
|
|
|
|
|
Adjusted
|
|
|
Operating Income
|
|
2024
|
|
|
Adjustments(2)
|
|
|
2024
|
|
|
2023
|
|
|
Adjustments(2)
|
|
|
2023
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flavors & Extracts
|
|
$
|
75,749
|
|
|
$
|
-
|
|
|
$
|
75,749
|
|
|
$
|
69,714
|
|
|
$
|
-
|
|
|
$
|
69,714
|
|
|
Color
|
|
|
92,987
|
|
|
|
-
|
|
|
|
92,987
|
|
|
|
84,027
|
|
|
|
-
|
|
|
|
84,027
|
|
|
Asia Pacific
|
|
|
25,963
|
|
|
|
-
|
|
|
|
25,963
|
|
|
|
24,911
|
|
|
|
-
|
|
|
|
24,911
|
|
|
Corporate & Other
|
|
|
(45,116
|
)
|
|
|
5,775
|
|
|
|
(39,341
|
)
|
|
|
(31,692
|
)
|
|
|
-
|
|
|
|
(31,692
|
)
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated
|
|
$
|
149,583
|
|
|
$
|
5,775
|
|
|
$
|
155,358
|
|
|
$
|
146,960
|
|
|
$
|
-
|
|
|
$
|
146,960
|
|
(2) Adjustments consist of Portfolio Optimization Plan costs.
Reconciliation of Non-GAAP Amounts - Continued
The following table summarizes the percentage change in the 2024 results compared to the
2023 results for the corresponding periods.
| |
|
Three Months Ended September 30, 2024
|
|
|
Revenue
|
|
Total
|
|
|
Foreign
Exchange
Rates
|
|
|
Adjustments(3)
|
|
|
Adjusted
Local
Currency
|
|
|
Flavors & Extracts
|
|
|
6.4
|
%
|
|
|
(0.4
|
%)
|
|
|
N/A
|
|
|
|
6.8
|
%
|
|
Color
|
|
|
11.8
|
%
|
|
|
(1.2
|
%)
|
|
|
N/A
|
|
|
|
13.0
|
%
|
|
Asia Pacific
|
|
|
13.6
|
%
|
|
|
0.2
|
%
|
|
|
N/A
|
|
|
|
13.4
|
%
|
|
Total Revenue
|
|
|
7.9
|
%
|
|
|
(0.7
|
%)
|
|
|
N/A
|
|
|
|
8.6
|
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flavors & Extracts
|
|
|
12.1
|
%
|
|
|
(0.7
|
%)
|
|
|
0.0
|
%
|
|
|
12.8
|
%
|
|
Color
|
|
|
30.0
|
%
|
|
|
(0.9
|
%)
|
|
|
0.0
|
%
|
|
|
30.9
|
%
|
|
Asia Pacific
|
|
|
15.0
|
%
|
|
|
(0.3
|
%)
|
|
|
0.0
|
%
|
|
|
15.3
|
%
|
|
Corporate & Other
|
|
|
51.1
|
%
|
|
|
0.1
|
%
|
|
|
12.6
|
%
|
|
|
38.4
|
%
|
|
Total Operating Income
|
|
|
13.4
|
%
|
|
|
(1.0
|
%)
|
|
|
(2.7
|
%)
|
|
|
17.1
|
%
|
|
Diluted Earnings Per Share
|
|
|
2.7
|
%
|
|
|
(1.3
|
%)
|
|
|
(4.0
|
%)
|
|
|
8.0
|
%
|
|
Adjusted EBITDA
|
|
|
12.0
|
%
|
|
|
(0.8
|
%)
|
|
|
N/A
|
|
|
|
12.8
|
%
|
| |
|
Nine Months Ended September 30, 2024
|
|
|
Revenue
|
|
Total
|
|
|
Foreign
Exchange
Rates
|
|
|
Adjustments(3)
|
|
|
Adjusted
Local
Currency
|
|
|
Flavors & Extracts
|
|
|
8.5
|
%
|
|
|
0.2
|
%
|
|
|
N/A
|
|
|
|
8.3
|
%
|
|
Color
|
|
|
5.0
|
%
|
|
|
(0.2
|
%)
|
|
|
N/A
|
|
|
|
5.2
|
%
|
|
Asia Pacific
|
|
|
6.9
|
%
|
|
|
(2.5
|
%)
|
|
|
N/A
|
|
|
|
9.4
|
%
|
|
Total Revenue
|
|
|
6.7
|
%
|
|
|
(0.2
|
%)
|
|
|
N/A
|
|
|
|
6.9
|
%
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flavors & Extracts
|
|
|
8.7
|
%
|
|
|
(0.1
|
%)
|
|
|
0.0
|
%
|
|
|
8.8
|
%
|
|
Color
|
|
|
10.7
|
%
|
|
|
(0.1
|
%)
|
|
|
0.0
|
%
|
|
|
10.8
|
%
|
|
Asia Pacific
|
|
|
4.2
|
%
|
|
|
(3.3
|
%)
|
|
|
0.0
|
%
|
|
|
7.5
|
%
|
|
Corporate & Other
|
|
|
42.4
|
%
|
|
|
0.1
|
%
|
|
|
18.2
|
%
|
|
|
24.1
|
%
|
|
Total Operating Income
|
|
|
1.8
|
%
|
|
|
(0.7
|
%)
|
|
|
(3.9
|
%)
|
|
|
6.4
|
%
|
|
Diluted Earnings Per Share
|
|
|
(5.1
|
%)
|
|
|
(0.8
|
%)
|
|
|
(5.2
|
%)
|
|
|
0.9
|
%
|
|
Adjusted EBITDA
|
|
|
5.0
|
%
|
|
|
(0.5
|
%)
|
|
|
N/A
|
|
|
|
5.5
|
%
|
(3) Adjustments consist of Portfolio Optimization Plan costs.
Reconciliation of Non-GAAP Amounts - Continued
The following table summarizes the reconciliation between Consolidated Operating Income (GAAP) and Adjusted EBITDA for the three and nine months ended
September 30, 2024 and 2023.
| |
|
Three Months Ended September 30,
|
|
|
Nine Months Ended September 30,
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
2024
|
|
|
2023
|
|
|
% Change
|
|
|
2024
|
|
|
2023
|
|
|
% Change
|
|
|
Operating income (GAAP)
|
|
$
|
50,520
|
|
|
$
|
44,531
|
|
|
|
13.4
|
%
|
|
$
|
149,583
|
|
|
$
|
146,960
|
|
|
|
1.8
|
%
|
|
Depreciation and amortization
|
|
|
15,460
|
|
|
|
14,770
|
|
|
|
|
|
|
|
45,185
|
|
|
|
43,360
|
|
|
|
|
|
|
Share-based compensation expense
|
|
|
2,069
|
|
|
|
2,519
|
|
|
|
|
|
|
|
6,980
|
|
|
|
7,285
|
|
|
|
|
|
|
Portfolio Optimization Plan costs, before tax
|
|
|
1,211
|
|
|
|
-
|
|
|
|
|
|
|
|
5,775
|
|
|
|
-
|
|
|
|
|
|
|
Adjusted EBITDA
|
|
$
|
69,260
|
|
|
$
|
61,820
|
|
|
|
12.0
|
%
|
|
$
|
207,523
|
|
|
$
|
197,605
|
|
|
|
5.0
|
%
|
The following table summarizes the reconciliation between Debt (GAAP) and Net Debt, and Operating Income (GAAP) and Credit Adjusted EBITDA for the trailing twelve months ended September
30, 2024 and 2023.
| |
|
September 30,
|
|
|
Debt
|
|
2024
|
|
|
2023
|
|
|
Short-term borrowings
|
|
$
|
17,811
|
|
|
$
|
22,807
|
|
|
Long-term debt
|
|
|
625,627
|
|
|
|
648,556
|
|
|
Credit Agreement adjustments(4)
|
|
|
(22,633
|
)
|
|
|
(19,463
|
)
|
|
Net Debt
|
|
$
|
620,805
|
|
|
$
|
651,900
|
|
| |
|
|
|
|
|
|
|
|
|
Operating income (GAAP)
|
|
$
|
157,646
|
|
|
$
|
188,185
|
|
|
Depreciation and amortization
|
|
|
59,645
|
|
|
|
56,565
|
|
|
Share-based compensation expense
|
|
|
8,628
|
|
|
|
10,947
|
|
|
Portfolio Optimization Plan costs, before tax
|
|
|
33,616
|
|
|
|
-
|
|
|
Other non-operating gains(5)
|
|
|
(998
|
)
|
|
|
(3,783
|
)
|
|
Credit Adjusted EBITDA
|
|
$
|
258,537
|
|
|
$
|
251,914
|
|
| |
|
|
|
|
|
|
|
|
|
Net Debt to Credit Adjusted EBITDA
|
|
|
2.4
|
x
|
|
|
2.6
|
x
|
(4) Adjustments include cash and cash equivalents, as described in the Company’s Third Amended and Restated Credit Agreement (Credit Agreement), and
certain letters of credit and hedge contracts.
(5) Adjustments consist of certain financing transaction costs, certain non-financing interest items, and gains and losses related to certain non-cash,
non-operating, and/or non-recurring items as described in the Credit Agreement.
The following table summarizes the reconciliation between Diluted Earnings Per Share (GAAP) and Adjusted Diluted Earnings Per Share for the twelve months ended
December 31, 2023.
|
Twelve Months Ended December 31,
|
|
|
|
| |
|
2023
|
|
|
Diluted earnings per share (GAAP)
|
|
$
|
2.21
|
|
|
Portfolio Optimization Plan costs, net of tax
|
|
|
0.65
|
|
|
Adjusted diluted earnings per share
|
|
$
|
2.86
|
|
Note: Earnings per share calculations may not foot due to rounding differences.
We have included each of these non-GAAP measures in order to provide additional information regarding our underlying operating results and comparable period-over-period performance.
Such information is supplemental to information presented in accordance with GAAP and is not intended to represent a presentation in accordance with GAAP. These non-GAAP measures should not be considered in isolation. Rather, they should be
considered together with GAAP measures and the rest of the information included in this release and our SEC filings. Management internally reviews each of these non-GAAP measures to evaluate performance on a comparative period-to-period basis
and to gain additional insight into underlying operating and performance trends, and we believe the information can be beneficial to investors for the same purposes. These non-GAAP measures may not be comparable to similarly titled measures
used by other companies.
